Published in Diabetes Week, June 30th, 2003
Matthias Herz and colleagues at Eli Lilly and Company randomly assigned 297 type 2 diabetic patients, 24 to 85 years old, to receive 30 mg pioglitazone daily (n=99), 45 mg pioglitazone daily (n=99), or placebo (n=99) for 16 weeks. Average body mass index (BMI) of the patients was 31.4 kg/m2, and average duration of diabetes was 20.0 months. None of the patients had...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.